- 1、本文档共4页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
_临床Ⅰ和Ⅱ期肺癌纵隔淋巴结微小转移灶的研究
·160 · 2005 3 27 3 Chin J Oncol, March 2005, Vol 27, No.3
··
ⅠⅡ
毛友生 张德超 张宏图 孙耘田 赵晓航 刘秀英 魏国联 刘芳
【】
。 32 Ⅰ Ⅱ181 ,
, Ber-Ep4 ,
HE , 。 15 (46.9%)
21 (11.6%)HE , Ber-Ep4
, 6 HE 。N0、
N1、N2 19, 6,7 , Ber-Ep4 7, 2, 6 ,
7 Ⅰb (N0)2 Ⅱb (N1)Ⅲa (N2)。32 、
, N2 0、18.8%46.9%。 ,
, Ber-Ep4 HE 。
。
【】 ; ; ; Ber-Ep4
Mediastinal lymph nodes mi cro-metastases in pati ents with clinical stage Ⅰ-Ⅱ lung cancer MAO You-
sheng, ZHANGDe-chao, ZHANGHong-tu, SUN Yun-tian, ZHAO X iao-hang, LIU Xiu-y ing, WEI Guo-lian,
LI U Fang .Depa tment of Tho acicSu ge y, Cance Institute(Hospital), Chinese Academy of Medical Sciences and
Peking Union Medical Unive sity, B eij ing 100021, China
Co esponding autho :MAO You-sheng, E-mail:Maoys @
【Abstract】 Objectiv e To in estigate micro-metastasis in mediastinal lymph nodes (mLN)of patients with
clinical stage Ⅰ~ Ⅱlung cancer and its clinical significance.Methods A total of 181 mLN from 32 lung cancer
patients in clinical stage Ⅰ~ Ⅱ were collected during operation and their frozen sections at two different le els
were examined immunohistochemically (IHC)with an anti-epithelial cell monoclonal antibody Ber-Ep4.Routine
HE staining was done for comparison.The results were processed by Chi-square tests in SPSS 10.0 soft ware.
Results Fifteen of the 32 patients (46.9%)were found to ha e micro-metastasis in 21 of 181 mLN (11.6%)
examined by immunohistochemical staining though routine histopathological examinations were negati e.Of those 15
cases, micro-metastasis was detected in 9 only by IHC and in 6 both by IHC and HE stainings.The positi e rate of
micro-metastasis in N0, N1, and N2 stratified by routine pathology was 36.8% (7/19), 33.3%(2/6)and 85.
7%(6/7), respecti ely (N0 s N2, P0.05).When stratified according to clinical staging (cTNM ),
pathological staging (pTNM)and pathological staging
文档评论(0)